Cargando…
Circulating Galectin-3 levels and Diabetic Nephropathy: a systematic review and meta-analysis
AIMS: Changes of serum galectin-3 (Gal-3) is associated with the pathogenesis of diabetic nephropathy (DN). However, current literature indicates that the given results remain debatable and inconsistent. Hence, the aim of this present meta-analysis was to focus on the predictive role of serum Gal-3...
Autores principales: | Guo, Yong, Li, Ling, Hu, Shanbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249253/ https://www.ncbi.nlm.nih.gov/pubmed/37291488 http://dx.doi.org/10.1186/s12882-023-03226-x |
Ejemplares similares
-
Correction to: Circulating galectin-3 levels and diabetic nephropathy: a systematic review and meta-analysis
por: Guo, Yong, et al.
Publicado: (2023) -
Galectin-3 as a prognostic biomarker for diabetic nephropathy
por: Hodeib, Hossam, et al.
Publicado: (2019) -
Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis
por: Yong, Guo, et al.
Publicado: (2023) -
Depression in type 1 diabetes was associated with high levels of circulating galectin-3
por: Melin, Eva Olga, et al.
Publicado: (2018) -
Preprocedural circulating galectin-3 and the risk of mortality after transcatheter aortic valve replacement: a systematic review and meta-analysis
por: Zhang, Hong-liang, et al.
Publicado: (2020)